Cover Image
市場調查報告書

全球植物性、植物來源藥物市場預測 (∼2027年):類固醇,酚,terupen,糖苷等,Sativex,Marinol Nabilone,Dexanabinol,CT-3,Cannabinor,HU 308,HU 331,重組的Taranabant的主要企業的展望

Botanical & Plant-Derived Drugs Market Forecast to 2027: Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides & Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant

出版商 Visiongain Ltd 商品編碼 602843
出版日期 內容資訊 英文 164 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球植物性、植物來源藥物市場預測 (∼2027年):類固醇,酚,terupen,糖苷等,Sativex,Marinol Nabilone,Dexanabinol,CT-3,Cannabinor,HU 308,HU 331,重組的Taranabant的主要企業的展望 Botanical & Plant-Derived Drugs Market Forecast to 2027: Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides & Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant
出版日期: 2017年12月19日 內容資訊: 英文 164 Pages
簡介

一般認為全球植物性、植物來源藥物市場將以今後以年複合成長率6.8%擴大。酚有市場30.2%的佔有率。

本報告提供全球植物性、植物來源藥物市場相關調查,市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業的簡介等彙整資料。

第1章 本報告概要

第2章 植物性、植物來源藥物的簡介

第3章 全球植物性、植物來源藥物市場

  • 全球市場預測
  • 各分類市場佔有率
  • 銷售額預測
    • SWOT分析
  • 酚市場區隔
  • 萜烯市場隔場
  • 糖苷市場區隔
  • 其他的各市場區隔市場
  • 品牌

第4章 各用途市場

  • 各子市場區隔市場佔有率
  • 荷爾蒙疾病
  • 感染疾病
  • 疼痛、中樞神經系統疾病
  • 心血管疾病、代謝性疾病
  • 呼吸系統疾病、腫瘤

第5章 主要國家市場

  • 各地區明細
  • 各地區市場預測

第6章 北美市場

第7章 歐洲市場

第8章 亞太地區市場

第9章 南美市場

第10章 中東、非洲市場

第11章 主要企業

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Bristol-Myers Squibb
  • Medigene AG

第12章 結論

附錄

目錄
Product Code: PHA0270

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures- all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Botanical and Plant-derived Drugs Market forecast to 2027
  • This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
    • Steroids
    • Phenols
    • Terpenes
    • Glycosides
    • Others

This report provides a SWOT analysis for each submarket.

  • This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
    • Hormone Diseases
    • Infectious Diseases
    • Pain & Central Nervous System Disorders
    • Cardiovascular & Metabolic Diseases
    • Respiratory & Oncology Diseases
  • Our work also shows individual revenue forecasts to 2027 for these regional and national markets
    • North America: US & Canada
    • Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
    • Asia-Pacific: China, Japan, India, Rest of APAC
    • Latin America: Brazil, Mexico, Rest of Latin America
    • Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa

Each regional market if further segmented by type and by application.

  • This report discusses several brands, including:
    • Sativex (GW Pharmaceuticals)
    • Marinol (Unimed Pharmaceuticals)
    • Nabilone / Cesamet (Valeant Pharmaceuticals)
    • Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
    • CT-3 (Indevus Pharmaceuticals)
    • Cannabinor (Pharmos)
    • HU 308 (Pharmos)
    • HU 331 (Cayman Chemical)
    • Rimonabant / Acomplia (Sanofi-Aventis)
    • Taranabant / MK-0364 (Merck & Co.)
  • This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
    • Abbott Laboratories
    • Bayer AG
    • Eli Lilly
    • Johnson & Johnson
    • Novartis AG
    • Pfizer, Inc.
    • Bristol-Myers Squibb (BMS)
    • Medigene AG
  • This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.

Visiongain's study is for everybody needing commercial analyses for the global botanical and plat derived-drugs market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Botanical and Plant-Derived Drugs Market Overview
  • 1.2. Overview of Findings
  • 1.3. Structure of the Report
  • 1.4. Global Botanical and Plant-Derived Drugs Market Segmentation
  • 1.5. Why You Should Read This Report
  • 1.6. How This Report Delivers
  • 1.7. Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9. Methodology
  • 1.10. Associated Visiongain Reports
  • 1.11. About Visiongain

2. Introduction to Botanical and Plant-Derived Drugs

  • 2.1. An Introduction to Botanical and Plant-Derived Drugs
  • 2.2. Plants with Antidiabetic Activity
  • 2.3. Plants with Anticancer Activity
  • 2.4. Steroids
  • 2.5. Phenols
  • 2.6. Terpenes
  • 2.7. Glycosides
  • 2.8. Drivers
    • 2.8.1. Increasing prevalence of various chronic diseases
    • 2.8.2. Cost effective
    • 2.8.3. Increasing Investment in botanical and plant-derived drugs
  • 2.9. Restrains
    • 2.9.1. Stringent laws and regulations for approval of botanical drugs
  • 2.10. Regulation

3. Global Botanical and Plant-Derived Drugs Market 2017-2027

  • 3.1. Global Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 3.2. Changing Market Shares by Segment 2017-2027
  • 3.3. Global Steroids Segment Market: Sales Forecast 2017-2027
    • 3.3.1. SWOT Analysis of the Steroids Market, 2017-2027
      • 3.3.1.1.1. Physical Strength and Stamina
        • 3.3.1.2. Weakness
        • 3.3.1.2.1. Risk of Cardiovascular Diseases
      • 3.3.1.3. Opportunity
        • 3.3.1.3.1. Increasing popularity
      • 3.3.1.4. Threat
        • 3.3.1.4.1. Steroids are considered as illegal
  • 3.4. Global Phenols Segment Market: Sales Forecast 2017-2027
    • 3.4.1. SWOT Analysis of the Phenols Market, 2017-2027
      • 3.4.1.1. Strength
        • 3.4.1.1.1. Control of diseases
        • 3.4.1.1.2. Cost Effective
      • 3.4.1.2. Weakness
        • 3.3.1.2.1. Hazardous Waste
      • 3.4.1.3. Opportunity
        • 3.4.1.3.1. Increasing prevalence of cancer
      • 3.4.1.4. Threat
        • 3.4.1.4.1. Side Effects
  • 3.5. Global Terpenes Segment Market: Sales Forecast 2017-2027
    • 3.5.1. SWOT Analysis of the Terpenes Market, 2017-2027
      • 3.5.1.1. Strength
        • 3.5.2.1.1. Terpenoids may be used in combination with other chemotherapeutic drugs
      • 3.5.1.2. Weakness
        • 3.5.1.2.1. Synergistic Effects
      • 3.5.1.3. Opportunity
        • 3.5.1.3.1. Increasing Prevalence of Cancer
      • 3.5.1.4. Threat
        • 3.5.1.4.1. Side effects
  • 3.6. Global Glycosides Segment Market: Sales Forecast 2017-2027
    • 3.6.1. SWOT Analysis of the Glycosides Market, 2017-2027
      • 3.6.1.1. Strength
        • 3.6.1.1.1. Glycosides are one of the leading methods of curing heart disease
      • 3.6.1.2. Weakness
        • 3.6.1.2.1. Overdose of glycosides causes serious health problems
      • 3.6.1.3. Opportunity
        • 3.6.1.3.1. Increasing prevalence of Heart Diseases
      • 3.6.1.4. Threat
        • 3.6.1.4.1. Side Effects
  • 3.7. Global Others Segment Market: Sales Forecast 2017-2027
  • 3.8. Global Botanical and Plant-Derived Drugs Market: Brand
    • 3.8.1. Sativex (GW Pharmaceuticals)
    • 3.8.2. Marinol (Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals)
    • 3.8.3. Nabilone / Cesamet (Valeant Pharmaceuticals International)
    • 3.8.4. Dexanabinol (Solvay Pharmaceuticals acquired by Abbott Laboratories)
    • 3.8.5. CT-3(ajulemic acid) (Indevus Pharmaceuticals)
    • 3.8.6. Cannabinor (Pharmos)
    • 3.8.7. HU 308(Pharmos)
    • 3.8.8. HU 331(Cayman Chemical)
    • 3.8.9. Rimonabant / Acomplia (Sanofi-Aventis)
    • 3.8.10. Taranabant / MK-0364(Merck and Co.)

4. Global Botanical and Plant-Derived Drugs Market, by Application: Sales Forecast 2016-2027

  • 4.1. Changing Market Shares by Sub-Segment, 2017-2027
  • 4.2. Global Hormone Diseases Segment: Sales Forecast 2016-2027
  • 4.3. Global Infectious Diseases Segment: Sales Forecast 2016-2027
  • 4.4. Global Pain & Central Nervous System Disorders Segment: Sales Forecast 2016-2027
  • 4.5. Global Cardiovascular & Metabolic Diseases Segment: Sales Forecast 2016-2027
  • 4.6. Global Respiratory & Oncology Diseases Segment: Sales Forecast 2016-2027

5.Leading National Markets 2017-2027

  • 5.1.Geographical Breakdown of the World Botanical and Plant-Derived Drugs Market
  • 5.2. World Botanical and Plant-Derived Drugs Market: Regional Forecast 2017-2027
    • 5.2.1. How Will Regional Market Shares Change to 2027?

6. North America Botanical and Plant-Derived Drugs Market 2017-2027

  • 6.1. U.S. Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 6.2. Canada Botanical and Plant-Derived Drugs Market: Trends and Developments

7. Europe Botanical and Plant-Derived Drugs Market 2017-2027

  • 7.1. Germany Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 7.2. France Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 7.3. U.K. Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 7.4. Italy Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 7.5. Spain Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 7.6. Rest of Europe Botanical and Plant-Derived Drugs Market Forecast 2017-2027

8. Asia Pacific Botanical and Plant-Derived Drugs Market 2017-2027

  • 8.1. China Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 8.2. Japan Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 8.3. India Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 8.4. Rest of Asia Pacific Botanical and Plant-Derived Drugs Market: Trends and Developments

9. Latin America Botanical and Plant-Derived Drugs Market 2017-2027

  • 9.1. Brazil Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 9.2. Mexico Botanical and Plant-Derived Drugs Market: Trends and Developments
  • 9.3. Rest of Latin America Botanical and Plant-Derived Drugs Market: Trends and Developments

10. Middle East and Africa Botanical and Plant-Derived Drugs Market 2017-2027

  • 10.1. Saudi Arabia Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 10.2. South Africa Botanical and Plant-Derived Drugs Market Forecast 2017-2027
  • 10.3. Rest of Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast 2017-2027

11. Leading Companies in the Botanical and Plant-Derived Drugs Market

  • 11.1. Abbott Laboratories
    • 11.1.1. Abbott Laboratories: Botanical and Plant-Derived Drugs Product Portfolio
    • 11.1.2. Financial Overview
    • 11.1.3. Recent Transactions Summary
  • 11.2. Bayer AG
    • 11.2.1. Bayer AG: Botanical and Plant-derived Drugs Portfolio
    • 11.2.2. Financial Overview
    • 11.2.3. Recent Transactions Summary
  • 11.3. Eli Lilly and Company
    • 11.3.1. Eli Lilly and Company: Botanical and Plant-derived Drugs Portfolio
    • 11.3.2. Financial Overview
    • 11.3.3. Recent Transactions Summary
  • 11.4. Johnson & Johnson
    • 11.4.1. Johnson & Johnson: Botanical and Plant-Derived Drugs Portfolio
    • 11.4.2. Financial Overview
    • 11.4.3.Recent Transactions Summary
  • 11.5. Novartis AG
    • 11.5.1. Novartis: Botanical and Plant-Derived Drugs Product Portfolio
    • 11.5.3. Novartis: Recent Developments
  • 11.6. Pfizer, Inc.
    • 11.6.1. Pfizer, Inc.: Botanical and Plant-Derived Drugs Portfolio
    • 11.6.2. Pfizer, Inc.: Financial Overview
    • 11.6.3. Pfizer, Inc.: Recent Developments
  • 11.7. Bristol-Myers Squibb
    • 11.7.1. Bristol-Myers Squibb: Botanical and Plant-derived Drugs Portfolio
    • 11.7.2. Bristol-Myers Squibb: Financial Overview
    • 11.7.3. Bristol-Myers Squibb: Recent Developments
  • 11.8. Medigene AG
    • 11.8.1. Medigene AG: Botanical and Plant-derived Drugs Portfolio
    • 11.8.2. Medigene AG: Financial Overview
    • 11.8.3. Medigene AG: Recent Developments

12. Conclusions

  • 12.1. The World Botanical and Plant-derived Drugs Market in 2016 and 2017
    • 12.1.1. Current Leading Botanical and Plant-derived Drugs Segments
    • 12.1.2. Leading Regional Markets
  • 12.2. World Botanical and Plant-derived Drugs Market Forecast 2017-2027
  • 12.3. The Future of the Botanical and Plant-derived Drugs Market?

Table of Tables

  • Table 2.1. Some Plants having Hypoglycemic Activity
  • Table 2.2. List of Herbs Commonly Used in Cancer Treatment
  • Table 3.1. Global Botanical and Plant-Derived Drugs Market by Product Type: Revenue($m) and Market Share(%), 2016
  • Table 3.2. Global Botanical and Plant-Derived Drugs Market Forecast, By Types of Plant Drugs: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 3.3. Global Steroids Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 3.4. SWOT Analysis of the Steroids Market, 2017-2027
  • Table 3.5. Global Phenols Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 3.6. SWOT Analysis of the Phenols Market, 2017-2027
  • Table 3.7. Global Terpenes Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 3.8. SWOT Analysis of the Terpenes Market, 2017-2027
  • Table 3.9. Global Glycosides Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 3.10. SWOT Analysis of the Glycosides Market, 2017-2027
  • Table 3.11. Global Others Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.1. Global Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.2. Global Hormone Diseases Segment Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.3. Global Infectious Diseases Segment Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.4. Global Pain & Central Nervous System Disorders Segment Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.5. Global Cardiovascular & Metabolic Diseases Segment Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.6. Global Respiratory & Oncology Diseases Segment Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.1. Global Botanical and Plant-Derived Drugs Market by Region: Revenue($m), 2016 and 2017
  • Table 5.2. Global Botanical and Plant-Derived Drugs Market Forecast, by Region: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 6.1. North America Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 6.2. North America Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 6.3. North America Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 6.4. US Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 6.5. Canada Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 7.1. Europe Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 7.2. Europe Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 7.3. Europe Botanical and Plant-Derived Drugs Market Forecast, By Country: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 7.4. Germany Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 7.5. France Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 7.6. U.K. Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 7.7. Italy Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 7.8. Spain Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 7.9. Rest of Europe Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 8.1. Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 8.2. Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 8.3. Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 8.4. China Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 8.5. Japan Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 8.6. India Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 8.7. Rest of Asia Pacific Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 9.1. Latin America Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 9.2. Latin America Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 9.3. Latin America Botanical and Plant-Derived Drugs Market Forecast, By Country, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 9.4. Brazil Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 9.5. Mexico Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 9.6. Rest of Latin America Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 10.1. Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, By Product Type: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 10.2. Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, By Application: Revenues($m), AGR(%), CAGR(%), 2016-2027
  • Table 10.3. Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast, by Country 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 10.4. Saudi Arabia Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 10.5. South Africa Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 10.6. Rest of MEA Botanical and Plant-Derived Drugs Market Forecast, 2016-2027($m, AGR %, CAGR %, Cumulative)
  • Table 11.1. Abbott Laboratories: Overview, 2017
  • Table 11.2. Abbott Laboratories: Revenue($m), AGR(%), 2012-2016
  • Table 11.3. Bayer AG: Overview, 2017
  • Table 11.4. Bayer AG: Revenue($m), AGR(%), 2012-2016
  • Table 11.5. Eli Lilly and Company: Overview, 2017
  • Table 11.6. Eli Lilly and Company: Revenue($m), AGR(%), 2012-2016
  • Table 11.7. Johnson & Johnson: Overview, 2017
  • Table 11.8. Johnson & Johnson: Revenue($m), AGR(%), 2012-2016
  • Table 11.9. Novartis: Overview, 2017
  • Table 11.10. Novartis: Revenue($m), AGR(%), 2012-2016
  • Table 11.11. Pfizer, Inc.: Overview, 2017
  • Table 11.12. Pfizer, Inc.: Revenue($m), AGR(%), 2011-2015
  • Table 11.13. Bristol-Myers Squibb: Overview, 2017
  • Table 11.14. Bristol-Myers Squibb: Revenue($m), AGR(%), 2012-2016
  • Table 11.15. Medigene AG: Overview, 2017
  • Table 11.16. Medigene AG: Revenue($m), AGR(%), 2012-2016
  • vTable of Figures
  • Figure 1.1. Global Botanical and Plant-Derived Drugs Market Segmentation Overview
  • Figure 3.1. Global Botanical and Plant-Derived Drugs Market by Product Type: Market Share(%), 2016
  • Figure 3.2. Global Botanical and Plant-Derived Drugs Market Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 3.3. Global Botanical and Plant-Derived Drugs Market by Types of Plant Drugs: Market Share(%), 2016
  • Figure 3.4. Global Botanical and Plant-Derived Drugs Market by Types of Plant Drugs: Market Share(%), 2021
  • Figure 3.5. Global Botanical and Plant-Derived Drugs Market by Types of Plant Drugs: Market Share(%), 2027
  • Figure 3.6. Global Steroids Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 3.7. Global Phenols Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 3.8. Global Terpenes Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 3.9. Global Glycosides Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 3.10. Global Others Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.1. Global Botanical and Plant-Derived Drugs Market by Application: Market Share(%), 2016
  • Figure 4.2. Global Botanical and Plant-Derived Drugs Market by Application: Market Share(%), 2021
  • Figure 4.3. Global Botanical and Plant-Derived Drugs Market by Application: Market Share(%), 2027
  • Figure 4.4. Global Hormone Diseases Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.5. Global Infectious Diseases Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.6. Global Pain & Central Nervous System Disorders Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.7. Global Cardiovascular & Metabolic Diseases Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.8. Global Respiratory & Oncology Diseases Segment Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.1. World Botanical and Plant-Derived Drugs Market: Revenues($m) by Region, 2016
  • Figure 5.2. World Botanical and Plant-Derived Drugs Market: Revenues($m) by Region, 2017
  • Figure 5.3. Global Botanical and Plant-Derived Drugs Market Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.4. Global Botanical and Plant-Derived Drugs Market Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.5. World Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 5.6. World Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 5.7. World Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 6.1. North America Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 6.2. North America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 6.3. North America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 6.4. North America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 6.5. US Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 6.6. Canada Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.1. Europe Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.2. Europe Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 7.3. Europe Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 7.4. Europe Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 7.5. Germany Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.6. France Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.7. U.K. Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.8. Italy Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.9. Spain Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 7.10. Rest of Europe Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 8.1. Asia Pacific Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 8.2. Asia Pacific Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 8.3. Asia Pacific Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 8.4. Asia Pacific Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 8.5. China Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 8.6. Japan Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 8.7. India Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 8.8. Rest of Asia Pacific Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 9.1. Latin America Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 9.2. Latin America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 9.3. Latin America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 9.4. Latin America Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 9.5. Brazil Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 9.6. Mexico Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 9.7. Rest of Latin America Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 10.1. Middle East and Africa Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 10.2. Middle East and Africa Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2016
  • Figure 10.3. Middle East and Africa Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2021
  • Figure 10.4. Middle East and Africa Botanical and Plant-Derived Drugs Market: Market Shares(%) by Regional Market, 2027
  • Figure 10.5. Saudi Arabia Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 10.6. South Africa Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AGR(%), 2016-2027
  • Figure 10.7. Rest of MEA Botanical and Plant-Derived Drugs Market Forecast: Revenues($m), AsGR(%), 2016-2027
  • Figure 11.1. Abbott Laboratories: Revenue($m), AGR(%), 2012-2016
  • Figure 11.2. Abbott Laboratories: Business Segment Revenue Share(%), 2016
  • Figure 11.3. Bayer AG: Revenue($m), AGR(%), 2012-2016
  • Figure 11.4. Bayer AG: Business Segment Revenue Share(%), 2016
  • Figure 11.5. Eli Lilly and Company: Revenue($m), AGR(%), 2012-2016
  • Figure 11.6. Eli Lilly and Company: Geographic Segment Revenue Share(%), 2016
  • Figure 11.7. Johnson & Johnson: Revenue($m), AGR(%), 2012-2016
  • Figure 11.8. Johnson & Johnson: Business Segment Revenue Share(%), 2016
  • Figure 11.9. Novartis: Revenue($m), AGR(%), 2012-2016
  • Figure 11.10. Novartis: Revenue, by Region, Share(%), 2016
  • Figure 11.11. Pfizer, Inc.: Revenue($m), AGR(%), 2011-2015
  • Figure 11.12. Pfizer, Inc.: National Revenue Share(%), 2015
  • Figure 11.13. Bristol-Myers Squibb: Revenue($m), AGR(%), 2012-2016
  • Figure 11.14. Bristol-Myers Squibb: National Revenue Share(%), 2016
  • Figure 11.15. Medigene AG: Revenue($m), AGR(%), 2012-2016
  • Figure 11.16. Medigene AG: National Revenue Share(%), 2016
  • Figure 12.1. Global Botanical and Plant-derived Drugs Market by Product Type: Market Share(%), 2016
  • Figure 12.2. Botanical and Plant-derived Drugs Market, By Region Share(%), 2016, 2021, 2027

Companies Listed

  • Abbott Laboratories
  • AbCellera Biologics, Inc.
  • Abott Laboratories
  • Accelis Pharma
  • Alere, Inc.
  • Almirall, S.A.
  • Array BioPharma
  • Arzneimittelwerk
  • Asia Journal of Cancer Prevention
  • Baader Bank AG
  • Baxter International
  • Bayer AG
  • Bristol-Myers Squibb
  • Canadian Cancer Society
  • Cancer Research UK
  • Cayman Chemical
  • Centre for Chronic Disease Control & Prevention
  • China's Ministry of Health (MOH)
  • Eli Lilly and Company
  • EUFETS GmbH
  • European Medicines Agency
  • European PD Association (EPDA)
  • European Union
  • Food and Drug Administration (FDA)
  • Fougera Pharmaceuticals, inc.
  • Guggenheim Securities, LLC
  • GW Pharmaceuticals
  • Hospira
  • Indevus Pharmaceuticals
  • Indian Council of Medical Research (ICMR)
  • Institute for Health Metrics and Evaluation
  • International Agency for Research on Cancer (IARC)
  • Istat
  • Janssen Products, LP
  • Johnson & Johnson
  • McKinsey & Co
  • Medigene AG
  • Merck
  • Mitsui Norin Co. Ltd
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute of Health
  • National Kidney Foundation
  • Novartis International AG
  • Organisation for Economic Co-operation and Development (OECD)
  • Otsuka Pharmaceutical
  • Paladin Labs Inc.
  • Pfizer, Inc.
  • Pharmos
  • Press Information Bureau
  • Rome Foundation
  • Sandoz Inc.,
  • Sanofi S.A.
  • Solvay Pharmaceuticals
  • Solvay Pharmaceuticals
  • The United Nations
  • The World Bank
  • Trout Capital LLC
  • UNICANCER
  • Unimed Pharmaceuticals
  • US. National Cancer Institute
  • Valeant Pharmaceuticals International
  • World Health Organization
  • World Heart Federation
Back to Top